Name: FORTRESS BIOTECH INC (FBIO) Stock
Brand: FORTRESS BIOTECH INC
Rating: 5.5 (3 reviews)

FBIO Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

2 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

4 days ago - By: Fortress Biotech, Inc.

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout

12 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

17 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

24 days ago - By: Stocktwits - Mentions: VTI VXF

Why Is Fortress Biotech Stock Falling Today?

17 days ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Participate in October 2025 Investor Conferences

24 days ago - By: Benzinga - Mentions: DH HCTI LRMR PALI ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

24 days ago - By: Benzinga - Mentions: CALM CYTK AIR QUAD ...

Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

24 days ago - By: Fortress Biotech, Inc.

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing

24 days ago - By: Fortress Biotech, Inc.

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101

2 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Participate in September 2025 Investor Conferences

2 months ago - By: Fortress Biotech, Inc.

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Present at the Emerging Growth Conference

2 months ago - By: Zacks Investment Research - Mentions: PAHC

Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates

2 months ago - By: Fortress Biotech, Inc.

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

2 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

3 months ago - By: Zacks Investment Research - Mentions: RPTX

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: CHRS

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

3 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

3 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

3 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

4 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

4 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

5 months ago - By: Yahoo Finance - Mentions: TM DG MSCI ADT

Vanguard to add four more funds to investor proxy choice program

5 months ago - By: Yahoo Finance - Mentions: O FLS GTLS KIM ...

3 Reasons to Buy Realty Income Stock Like There's No Tomorrow

5 months ago - By: Yahoo Finance - Mentions: VNLA DD KKR STR ...

Janus Henderson Adds New Active Short Duration ETF in Europe

5 months ago - By: Fortress Biotech, Inc.

FORTRESS BIOTECH INC (FBIO) Stock News

FBIO Latest News, Press Relases and Analysis

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

Why Is Fortress Biotech Stock Falling Today?

Journey Medical Corporation to Participate in October 2025 Investor Conferences

12 Health Care Stocks Moving In Wednesday's Intraday Session

Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101

Journey Medical Corporation to Participate in September 2025 Investor Conferences

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Journey Medical Corporation to Present at the Emerging Growth Conference

Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

Vanguard to add four more funds to investor proxy choice program

3 Reasons to Buy Realty Income Stock Like There's No Tomorrow

Janus Henderson Adds New Active Short Duration ETF in Europe

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics